Publicly traded synbio companies — gene editing, AI drug discovery, DNA synthesis, sequencing, and cell therapy.
| Ticker | Company | Exchange | Category | Status |
|---|---|---|---|---|
| DNA | Ginkgo Bioworks | NYSE | platform | trading |
| TWST | Twist Bioscience | NASDAQ | platform | trading |
| ABSI | Absci Corporation | NASDAQ | platform | trading |
| RXRX | Recursion Pharmaceuticals | NASDAQ | ai-drug-discovery | trading |
| BEAM | Beam Therapeutics | NASDAQ | gene-editing | trading |
| CRBU | Caribou Biosciences | NASDAQ | gene-editing | trading |
| NTLA | Intellia Therapeutics | NASDAQ | gene-editing | trading |
| CRSP | CRISPR Therapeutics | NASDAQ | gene-editing | trading |
| ILMN | Illumina | NASDAQ | infrastructure | trading |
| EDIT | Editas Medicine | NASDAQ | gene-editing | trading |
| VERV | Verve Therapeutics | NASDAQ | gene-editing | trading |
| SANA | Sana Biotechnology | NASDAQ | cell-therapy | trading |
| SNTI | Senti Biosciences | NASDAQ | cell-therapy | trading |
| LNZA | LanzaTech | NASDAQ | biomanufacturing | trading |